advancing innovation to save lives

The Hill features op-ed from GHTC director

The Hill featured an op-ed from GHTC Director Jamie Bay Nishi which highlights the historic decline in US government investment in neglected disease R&D and calls for the US to increase funding and reassert American leadership in global health innovation.
View

R&D Facts

Be in the know. Discover important facts and figures about global health research and development on our R&D Facts page.
Learn More

Innovative Vector Control Consortium

Innovative Vector Control Consortium is a product development partnership funded by the Bill & Melinda Gates Foundation, the UK Agency for International Development, the US Agency for International Development, and the Swiss Agency for Development and Cooperation.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC issues statement on antimicrobial resistance at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board supporting the assembly’s resolution on antimicrobial resistance (AMR), which incorporates R&D as a vital part of WHO’s strategy to combat AMR. The statement also calls for WHO to accelerate efforts to develop accountability frameworks to ensure AMR commitments are realized. The statement was issued in partnership with the Global Health Council and PATH.

PDF
GHTC issues statement on R&D for epidemic diseases at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board, welcoming efforts by WHO to advance frameworks to catalyze development of new technologies to combat potentially epidemic diseases and support regulatory models and procurement systems to accelerate the pace at which these tools reach patients. The statement was issued in partnership with the Global Health Council and PATH.

PDF
View All News & Events

GHTC Event

Game changers in global health game night
GHTC
Learn More

Community Event

Brookings
Spurring private investment in health R&D around the world
Brookings
Learn More
View All Events
Office of Management and Budget
Trump budget proposes steep cuts to research and foreign assistance that will threaten global health research

What global health advocates need to know about the President's "skinny" budget.

Read More
Devex
Meet GHTC’s new director, Jamie Bay Nishi

GHTC's new director Jamie Bay Nishi talks about her background, what inspires her, and her vision for the future of the coalition.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide